Basit öğe kaydını göster

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

dc.contributor.authorFirat, Pinar
dc.contributor.authorTambas, Makbule
dc.contributor.authorCiftci, Rumeysa
dc.contributor.authorEralp, Yesim
dc.contributor.authorGuveli, Murat Emin
dc.contributor.authorAydiner, Adnan
dc.contributor.authorSen, Fatma
dc.contributor.authorOral, Ethem Nezih
dc.contributor.authorSaip, Pinar
dc.contributor.authorToker, Alper
dc.contributor.authorSaglam, Esra Kaytan
dc.contributor.authorOzkan, Berker
dc.contributor.authorOzkaya, Kubra
dc.contributor.authorDemir, Adalet
dc.date.accessioned2021-03-04T07:58:05Z
dc.date.available2021-03-04T07:58:05Z
dc.date.issued2016
dc.identifier.citationSen F., Tambas M., Ozkaya K., Guveli M. E. , Ciftci R., Ozkan B., Oral E. N. , Saglam E. K. , Saip P., Toker A., et al., "Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy", MEDICINE, cilt.95, sa.30, 2016
dc.identifier.issn0025-7974
dc.identifier.othervv_1032021
dc.identifier.otherav_60d3dd4f-f686-46d3-b50c-c67b3ef3cd77
dc.identifier.urihttp://hdl.handle.net/20.500.12627/67549
dc.identifier.urihttps://doi.org/10.1097/md.0000000000004280
dc.description.abstractPresently, there is no consensus regarding which chemotherapy regimen is best to administer with radiotherapy in patients with locally advanced non-small-cell lung cancer (LA-NSCLC). Herein, our aim was to compare the outcome of patients treated with either etoposide-cisplatin (EP) or docetaxel-cisplatin (DP) in this curative setting.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleConcomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
dc.typeMakale
dc.relation.journalMEDICINE
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume95
dc.identifier.issue30
dc.contributor.firstauthorID233453


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster